Delivery Order SPE2DB22D3102-SPE2DB25FL2NK
- Not listed
- The Defense Logistics Agency (DLA) awarded a $1,452.64 delivery order to AmerisourceBergen Drug Corp on August 26, 2025, for the supply of Phytonadione 10 mg/ml ampules. This is a firm fixed price contract with no set-aside designation, classified as a child contract under a larger vehicle. The place of performance is AmerisourceBergen's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of August 27, 2025. Phytonadione, commonly known as Vitamin K1, is a critical...
- The Defense Logistics Agency awarded a delivery order valued at $1,012.32 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes (0.5 mL units). This is a firm fixed-price delivery order with no set-aside designation, executed on July 31, 2025, with an ultimate completion date of August 1, 2025. The product will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. This delivery order is issued under AmerisourceBergen's larger Indefinite...
- The U.S. Department of Defense Medical Supply Chain awarded a $2,701.68 firm fixed-price delivery order to AmerisourceBergen Drug Corp for Phytonadione 10 mg/ml ampules, with an ultimate completion date of August 4, 2025. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with the Defense Logistics Agency Troop Support Medical, valued at $999,999,999.00 and extending through December 2026. The contract was competitively awarded...
- The Defense Logistics Agency (DLA) awarded a delivery order valued at $5,774.99 to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on July 28, 2025, with completion scheduled for July 29, 2025. This firm fixed-price delivery order, which carries no set-aside designation, was competitively awarded and represents a child contract under AmerisourceBergen's larger pharmaceutical supply agreement with DLA. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used...
- The Defense Logistics Agency awarded a $2,132.69 delivery order to AmerisourceBergen Drug Corp for Phytonadione 1 mg/0.5 mL syringes on June 13, 2025, with an ultimate completion date of June 16, 2025. This competitively awarded, firm fixed-price contract carries no set-aside designation and is being performed at AmerisourceBergen's Corporate Office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used to treat vitamin K...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 18, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $2,716.90, with completion targeted for July 21, 2025. This is a firm fixed-price contract with no set-aside designation, meaning it was awarded through open competition. AmerisourceBergen Drug Corp, headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order is issued...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on July 24, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes with a ceiling value of $20,559.12. This firm fixed-price delivery order, with an ultimate completion date of July 25, 2025, represents a competitively awarded contract with no set-aside designation. The product will be delivered to AmerisourceBergen's facility in Conshohocken, Pennsylvania. This delivery order is issued under...
- The Defense Logistics Agency Medical Supply Chain awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Phytonadione 10 mg/ml in ampule form, with a contract ceiling value of $2,026.26 and an ultimate completion date of September 4, 2025. This competitively awarded, non-set-aside delivery order carries firm fixed pricing and represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract with DLA Troop Support Medical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on June 3, 2025, for Phytonadione 1 mg/0.5 mL syringes with a contract ceiling value of $6,851.88. This is a firm fixed price delivery order with an ultimate completion date of June 4, 2025, and represents a non-set-aside competitive award. The order will be performed at AmerisourceBergen's corporate office location in Conshohocken, Pennsylvania. Phytonadione, commonly known as Vitamin K1, is a critical...
- The Defense Logistics Agency awarded a delivery order to AmerisourceBergen Drug Corp on September 3, 2025, for the supply of Phytonadione 1 mg/0.5 mL syringes valued at $47,007.95. This is a firm fixed-price delivery order with no set-aside designation, placing performance at the contractor's corporate office in Conshohocken, Pennsylvania, with an ultimate completion date of September 4, 2025. The award represents a competitive procurement under AmerisourceBergen's existing Indefinite Delivery...
- SPE2DB22D3102Indefinite Delivery Contract
- SPE2DB22D3102-SPE2DB25FL2NKDelivery Order
The Defense Logistics Agency awarded a delivery order valued at $1,350.84 to AmerisourceBergen Drug Corp for Phytonadione 10 mg/ml ampules, with an ultimate completion date of August 13, 2025. This firm fixed-price delivery order was competitively awarded with no set-aside designation. AmerisourceBergen Drug Corp, a major pharmaceutical distributor headquartered in Conshohocken, Pennsylvania, will perform the work at its corporate office location. This delivery order represents a child contract under AmerisourceBergen's larger Indefinite Delivery Contract (IDC) with DLA Troop Support Medical (SPE2DX), a $999,999,999.00 prime vendor agreement running through December 2026 that enables the company to supply comprehensive pharmaceutical products and medical supplies to support military healthcare programs globally. Phytonadione, commonly known as Vitamin K1, is a critical pharmaceutical used in medical settings for blood clotting disorders and as an antidote to anticoagulant overdose. The delivery order reflects AmerisourceBergen's role as a key supplier within the Defense Logistics Agency's medical supply chain, supporting military healthcare systems and other federal health programs. This transaction exemplifies the company's versatility in fulfilling federal medical procurement requirements across a broad spectrum of pharmaceutical commodities, from routine medications to specialized healthcare products, through its established competitive relationship with the DLA.
Mod # | Description | ReasonForModification | Federal Obligation | Date |
|---|---|---|---|---|
| Not listed | Not listed | $1.4k | 8/12/25 |